Chicago, Illinois
Alzheimer's disease clinical trials in Chicago, IL
14 Alzheimer's disease studies are recruiting participants at sites in Chicago as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Chicago at a glance
- 14 studies are recruiting at a site in Chicago.
- By phase: Phase 2 (1), Phase 3 (6), No phase (3), Observational (4). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (9), university, hospital or other (5).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Chicago
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Phase 3
- Ages 50 to 90
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Great Lakes Clinical Trials Chicago d/b/a Flourish Research Andersonville
- Registry record
- NCT07177352 · updated
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
- Phase 3
- Ages 55 to 80
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Great Lakes Clinical Trials Chicago d/b/a Flourish Research Andersonville
- Registry record
- NCT07717411 · updated
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Phase 3
- Ages 55 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Great Lakes Clinical Trials - Andersonville
- Registry record
- NCT07602582 · updated
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Phase 3
- Ages 60 to 85
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Re:Cognition Health - Chicago
- Registry record
- NCT06976216 · updated
CommunityRx-Dementia + Peer Navigation (CRxDpeer)
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- University of Chicago
- Study site
- University of Chicago
- Registry record
- NCT07346183 · updated
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Phase 3
- Ages 60 to 85
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Great Lakes Clinical Trials - Andersonville
- Registry record
- NCT06976203 · updated
Central Auditory Processing Modulation Underlying Anxiety Reduction Using Clinically Designed Improvisatory Music
- No phase
- Ages 55 and older
- All sexes
- Sponsor
- Northwestern University
- Study site
- Northwestern University Feinberg School of Medicine
- Registry record
- NCT07775625 · updated
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eidos Therapeutics, a BridgeBio company
- Study sites
- John H. Stroger, Jr. Hospital of Cook County · University of Chicago - Medical Center
- Registry record
- NCT06563895 · updated
Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
- Observational
- Ages 40 to 90
- All sexes
- Sponsor
- Neurogen Biomarking LLC
- Study site
- Insigth Hospital and Medical Center Chicago
- Registry record
- NCT07701161 · updated
Communication Bridge 3 Study
- Phase 2
- Ages 18 to 100
- All sexes
- Sponsor
- University of Chicago
- Study site
- University of Chicago - American School Building
- Registry record
- NCT06191198 · updated
Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
- No phase
- Ages 50 to 90
- All sexes
- Sponsor
- Northwestern University
- Study site
- Northwestern University
- Registry record
- NCT04240561 · updated
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Observational
- Ages 60 to 90
- All sexes
- Sponsor
- GAP Innovations, PBC
- Study site
- Flourish Research - Chicago
- Registry record
- NCT06584357 · updated
Feasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related Outcomes
- Observational
- Ages 18 to 65
- All sexes
- Sponsor
- PepsiCo Global R&D
- Study site
- Advanced Personalized Ideation Center (API) and Gatorade Sports Science Institute (GSSI), PepsiCo Global R&D - Life Sciences
- Registry record
- NCT07005895 · updated
Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Alzheimer's Disease and Related Disorders Association, Inc
- Study site
- Full List of Active Sites
- Registry record
- NCT06170268 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Chicago, IL on ClinicalTrials.gov.
Ask about studies near Chicago
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections